摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl 2-[4-(2,2,2-trifluoroethoxy)phenyl]acetate | 937603-34-4

中文名称
——
中文别名
——
英文名称
Methyl 2-[4-(2,2,2-trifluoroethoxy)phenyl]acetate
英文别名
——
Methyl 2-[4-(2,2,2-trifluoroethoxy)phenyl]acetate化学式
CAS
937603-34-4
化学式
C11H11F3O3
mdl
MFCD08696626
分子量
248.202
InChiKey
YGRMEWVUYCFYSX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    17
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Methyl 2-[4-(2,2,2-trifluoroethoxy)phenyl]acetate 在 lithium hydroxide 、 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 生成 2-[4-(2,2,2-三氟乙氧基)苯基]乙酸
    参考文献:
    名称:
    Novel benzimidazole derivatives as selective CB2 agonists
    摘要:
    The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (> 1000-fold) over the CB1 receptor. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.05.073
  • 作为产物:
    参考文献:
    名称:
    Novel benzimidazole derivatives as selective CB2 agonists
    摘要:
    The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (> 1000-fold) over the CB1 receptor. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.05.073
点击查看最新优质反应信息

文献信息

  • Novel benzimidazole derivatives as selective CB2 agonists
    作者:Daniel Pagé、Elise Balaux、Luc Boisvert、Ziping Liu、Claire Milburn、Maxime Tremblay、Zhongyong Wei、Simon Woo、Xuehong Luo、Yun-Xing Cheng、Hua Yang、Sanjay Srivastava、Fei Zhou、William Brown、Miroslaw Tomaszewski、Christopher Walpole、Leila Hodzic、Stéphane St-Onge、Claude Godbout、Dominic Salois、Keymal Payza
    DOI:10.1016/j.bmcl.2008.05.073
    日期:2008.7
    The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (> 1000-fold) over the CB1 receptor. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多